New dual ligands for the D2 and 5-HT1A receptors from the group of 1,8-naphthyl derivatives of LCAP

Bioorg Med Chem Lett. 2019 Aug 15;29(16):2236-2242. doi: 10.1016/j.bmcl.2019.06.029. Epub 2019 Jun 20.

Abstract

More than 300 million people are suffering from depression, one of the civilization diseases in the 21st century. Serotonin 5-HT1AR and dopamine D2R play an important role in the treatment and pathogenesis of depression. Moreover, in recent years, the efficacy of dual 5-HT1A/D2 receptors ligands has been demonstrated in the fight against depression. In this work the new bulky arylpiperazine derivatives (LCAP) were synthesized in microwave radiation field. The affinities for the selected serotonin (5-HT1A,5-HT2A,5-HT6,5-HT7) and dopamine (D2) receptors have been evaluated in vitro. Compounds 5.3a, 5.4, 5.1c, 5.3d, 5.2a are promising dual 5-HT1AR/D2R ligands. The SAR analysis were additionally supported with molecular docking studies.

Keywords: 5-HT(1A)/D(2); Depression; Microwave-assisted; Molecular modelling; Serotonin receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dopamine D2 Receptor Antagonists / chemical synthesis
  • Dopamine D2 Receptor Antagonists / chemistry
  • Dopamine D2 Receptor Antagonists / pharmacology*
  • Dose-Response Relationship, Drug
  • Humans
  • Ligands
  • Molecular Docking Simulation
  • Molecular Structure
  • Piperazine / chemical synthesis
  • Piperazine / chemistry
  • Piperazine / pharmacology*
  • Receptor, Serotonin, 5-HT1A / metabolism*
  • Receptors, Dopamine D2 / metabolism*
  • Serotonin Antagonists / chemical synthesis
  • Serotonin Antagonists / chemistry
  • Serotonin Antagonists / pharmacology*
  • Structure-Activity Relationship

Substances

  • Dopamine D2 Receptor Antagonists
  • Ligands
  • Receptors, Dopamine D2
  • Serotonin Antagonists
  • Receptor, Serotonin, 5-HT1A
  • Piperazine